Intuitive SurgicalISRG
ISRG
About: Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
Employees: 15,638
0
Funds holding %
of 7,425 funds
0
Analysts bullish %
of 6 analysts
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
251% more first-time investments, than exits
New positions opened: 270 | Existing positions closed: 77
16% more repeat investments, than reductions
Existing positions increased: 806 | Existing positions reduced: 693
9% more capital invested
Capital invested by funds: $145B [Q3] → $159B (+$13.7B) [Q4]
8% more funds holding
Funds holding: 1,918 [Q3] → 2,074 (+156) [Q4]
1.57% more ownership
Funds ownership: 83.45% [Q3] → 85.02% (+1.57%) [Q4]
1% more funds holding in top 10
Funds holding in top 10: 67 [Q3] → 68 (+1) [Q4]
10% less call options, than puts
Call options by funds: $1.44B | Put options by funds: $1.6B
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$470
17%
downside
Avg. target
$575
2%
upside
High target
$635
12%
upside
6 analyst ratings
5 positive
83%
1 neutral
17%
0 negative
0%
Barclays Matt Miksic 56% 1-year accuracy 22 / 39 met price target | 12%upside $635 | Overweight Maintained | 24 Apr 2025 |
RBC Capital Shagun Singh 48% 1-year accuracy 33 / 69 met price target | 7%upside $605 | Outperform Maintained | 23 Apr 2025 |
Truist Securities Richard Newitter 56% 1-year accuracy 28 / 50 met price target | 4%upside $590 | Buy Maintained | 23 Apr 2025 |
Piper Sandler Adam Maeder 64% 1-year accuracy 9 / 14 met price target | 2%upside $575 | Overweight Maintained | 23 Apr 2025 |
Evercore ISI Group Vijay Kumar 35% 1-year accuracy 15 / 43 met price target | 17%downside $470 | In-Line Maintained | 23 Apr 2025 |
Financial journalist opinion
Based on 41 articles about ISRG published over the past 30 days
Positive
Zacks Investment Research
1 day ago
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Neutral
CNBC Television
2 days ago
Trade Tracker: Stephanie Link sells Eli Lilly and buys more Intuitive Surgical
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to detail her latest portfolio moves.
Neutral
The Motley Fool
4 days ago
Prediction: 3 Stocks That Will Be Worth More Than Palantir Technologies 5 Years From Now
Few stocks have sizzled as much as Palantir Technologies (PLTR -1.49%) over the last 12 months. Shares of the data analytics software provider more than quadrupled during the period.
Neutral
The Motley Fool
6 days ago
With Competition Rising, Should Investors Give Up On This Top Growth Stock?
Intuitive Surgical (ISRG 1.13%) has delivered market-crushing returns over the past two decades, thanks to its leadership in the robotic-assisted surgery (RAS) market. Part of the company's appeal is that its crown jewel has had little competition.
Positive
Zacks Investment Research
1 week ago
The Transformative Rise of Global Robotics: A 2025 Market Analysis
Robotics is poised for robust growth in 2025. Watch NVDA, ISRG, SERV and PATH for potential market dominance across healthcare, manufacturing and mobility sectors.
Neutral
The Motley Fool
1 week ago
Got $5,000? 2 Unstoppable Growth Stocks to Buy Now and Hold Forever
Many investors would rather keep their money in their pockets right now. Equity markets have been volatile, the near term looks somewhat uncertain, and President Donald Trump's international trade policies might lead to more severe economic problems down the line.
Positive
Seeking Alpha
1 week ago
Stock Picks From Seeking Alpha's April 2025 New Analysts
In April, Seeking Alpha welcomed 20 new analysts. This article introduces them and showcases some of their top picks. Top picks include Palantir, Arch Capital Group, and Utah Medical Products, emphasizing an under-recognized growth driver, discounted valuation, and a substantial margin of safety. Analysts also highlighted Sell recommendations on Estée Lauder and Intuitive Surgical, citing deteriorating consumer sentiment and little price upside.
Positive
The Motley Fool
1 week ago
2 Stocks I Can't Wait to Buy During the Next Market Correction
Investors never know when the next market correction -- a drop of from 10% to 20% in an index -- is coming, but we know that it will eventually happen. And because that's true, it makes sense to make a list of the stocks you'd like to buy if they dip during a correction.
Neutral
The Motley Fool
1 week ago
Stock Market Selloff: 4 No-Brainer Stocks to Buy Right Now
In 2025, Wall Street has been rattled with increasing concerns about U.S.-China trade wars, escalating geopolitical pressures, rising economic uncertainties, and growing recession fears. The benchmark S&P 500 index is down nearly 4.7% in 2025.
Neutral
The Motley Fool
1 week ago
Prediction: 2 Stocks Will Be Worth More Than Palantir Technologies in 2026
Palantir Technologies is currently worth $269 billion. But these Wall Street analysts think Intuitive Surgical (ISRG 2.29%) and ServiceNow (NOW 2.00%) can top that figure in 2026:
Charts implemented using Lightweight Charts™